Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1464-2020Class II

RayStation/RayPlan 8B, Build Number 8.1.0.47, stand-alone software treatment planning system

RaySearch Laboratories AB (publ) / initiated 2020-02-20 / Terminated

RAYSEARCH LABORATORIES AB began a recall of RayStation/RayPlan 8B, Build Number 8.1.0.47, stand-alone software treatment planning system on . FDA classified it as Class II and gives the reason as "There is a potential for erroneous propagation of the current tabletop positions when applying pitch or roll correction. Even though pitch and roll correction is never propagated, non-zero pitch or roll causes the...". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-1464-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
RaySearch Laboratories AB (publ)
Product
RayStation/RayPlan 8B, Build Number 8.1.0.47, stand-alone software treatment planning system
Product code
MUJ System, Planning, Radiation Therapy Treatment
Reason for recall
There is a potential for erroneous propagation of the current tabletop positions when applying pitch or roll correction. Even though pitch and roll correction is never propagated, non-zero pitch or roll causes the lateral, longitudinal and vertical values propagated to be incorrect.
FDA root cause
Under Investigation by firm
Action
An Urgent Field Safety Notice, Medical Device Correction notification letter dated 2/19/20 was emailed to the customer. ACTIONS TO BE TAKEN BY THE USER " Either do not use the RayTreat tabletop propagation functionality or make sure to always perform imaging and registration correction before each treatment session. " When using RayTreat in combination with the ProNova machine, do not use the acquired imaging positions in the preparation tab as the truth about where an image was actually taken. Please educate all users including the planning, Quality Assurance and plan delivery staff about this workaround. Inspect your product and identify all installed units with the above software version number(s), then confirm you have read and understood this notice by replying to the notification email. SOLUTION This issue will be resolved in the next version of RayStation, scheduled for market release in March 2020 (subject to market clearance in some markets). If customers wish to continue using versions of RayStation affected by this notice, all users must maintain awareness of this notice. Alternatively, customers can choose to upgrade to the new version once it becomes available for clinical use. TRANSMISSION OF THIS NOTICE This notice needs to be passed on to all those who need to be aware within your organization. Please maintain awareness of this notice as long as any version of RayStation affected by this issue is in use to ensure effectiveness of the workaround.
Quantity in commerce
1 system in the U.S.
Distribution
The products were distributed to the following US states: TN
Product codes and lots
UDI 07350002010129

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1464-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1462-2020Class IITerminatedVoluntary: Firm initiated
Z-1463-2020Class IITerminatedVoluntary: Firm initiated
Z-1464-2020Class IITerminatedVoluntary: Firm initiated
Z-1465-2020Class IITerminatedVoluntary: Firm initiated
Z-1466-2020Class IITerminatedVoluntary: Firm initiated
Z-1467-2020Class IITerminatedVoluntary: Firm initiated
Z-1468-2020Class IITerminatedVoluntary: Firm initiated